PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 18, 2026Journal of Biological Chemistry0 citationsOpen Access

The Ion Channel, CFTR, assembles with HIPPO pathway proteins TAZ and YAP in polycystic kidney disease

View Full Paper
ASAbhishek SharmaMAMasoud AfshaniCCCristian Ciobanu

Key Points

  • This research aims to investigate the association of CFTR with HIPPO pathway proteins TAZ and YAP in renal cyst growth.
  • Utilized RC mutant mice and cell lines to study CFTR interactions with TAZ and YAP.
  • Measured co-localization of CFTR, TAZ, and YAP in kidney tissues from normal and RC mice, including VX-809 treatment.
  • Analyzed the effects of VX-809 on the localization of CFTR, TAZ, and YAP in the kidneys.
  • CFTR co-localization with TAZ and YAP at the apical membrane in RC mice indicates their role in cyst growth.
  • VX-809 treatment restores the normal basolateral location of CFTR, TAZ, and YAP in RC kidneys.
  • TAZ and YAP levels in the nucleus decrease to normal levels with VX-809 treatment, indicating a reduction in pro-proliferative effects.

Abstract

(RC) mutant mice and cell lines to study this phenomenon. We show that CFTR closely associates with the HIPPO pathway proteins TAZ and YAP. CFTR co-localizes strongly with TAZ and YAP in normal and RC mice and also in RC mice treated with VX-809. In RC mice, the co-localization of TAZ, YAP, and CFTR is predominately at the apical membrane; the abnormal accumulation of these three proteins at the apical membrane is indicative of their role in cyst growth. VX-809 treatment of RC kidneys restores CFTR, TAZ, and YAP to a basolateral location similar to that observed in the normal kidney. CFTR, TAZ, and YAP also co-localize with calnexin, a marker of the ER, with the highest co-localization in untreated RC kidneys. We show that both TAZ and YAP are increased in the nuclei of untreated RC kidneys as compared to normal kidneys. Importantly, VX-809 reduces TAZ and YAP in the nucleus to levels comparable to those in normal kidneys, providing mechanistic insight into how CFTR modulator therapy reduces proliferation.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Sharma et al. (2026) studied this question.

synapsesocial.com/papers/6a0aabc25ba8ef6d83b6f741https://doi.org/10.1016/j.jbc.2026.113152
Ask AI
Helpful
Bookmark
Share
View Full Paper